1.3%), with a hazard ratio of 3.3 (CI 1.4, 9.6)
GLP-1 medications a class of drugs originally developed to treat diabetes and now used for weight management and longevity help regulate appetite, gastric emptying, and post-meal glucose
Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, et al
Who are we A: We are headquartered in Xiamen, China, and our international markets: sold to North America (25.00%), South America (10.00%), Western Europe (10.00%), South Asia (10.00%), Oceania (8.00%), Eastern Europe (7.00%), Southern Europe (7.00%), Northern Europe (8.00%), Middle East (4.00%), Southeast Asia (7.00%), Africa (4.00%)
Unfortunately, the study was prematurely terminated and underpowered, which precludes a conclusive determination of the disease-modifying effects of exenatide for MCI or early AD in clinical settings [95]